Skip to main content

Enhancing diagnosis and treatment of superior cluneal nerve entrapment: cadaveric, clinical, and ultrasonographic insights

Abstract

Objectives

Low back pain is a prevalent public health issue caused by superior cluneal nerve (SCN) entrapment. This study aimed to explore the course of SCN branches, cross-sectional area (CSA) of the nerves, and effects of ultrasound-guided SCN hydrodissection.

Methods

SCN distance relative to the posterior superior iliac spines was measured and compared with ultrasound findings in asymptomatic volunteers. The CSA of the SCN, pressure-pain threshold, and pain measurements were obtained from asymptomatic controls and patients with SCN entrapment at various time points after hydrodissection (with 1 mL of 50% dextrose, 4 mL of 1% lidocaine, and 5 mL of 1% normal saline) in the short-axis view.

Results

Twenty sides of 10 formalin-fixed cadavers were dissected. The SCN locations on the iliac crest did not differ from the ultrasound findings in 30 asymptomatic volunteers. The average CSA of the SCN across different branches and sites ranged between 4.69–5.67 mm2 and did not vary across different segments/branches or pain statuses. Initial treatment success was observed in 77.7% (n = 28) of 36 patients receiving hydrodissection due to SCN entrapment. A group with initial treatment success experienced symptom recurrence in 25% (n = 7) of cases, and those with recurrent pain had a higher prevalence of scoliosis than those without symptom recurrence.

Conclusions

Ultrasonography effectively localizes SCN branches on the iliac crest, whereby increased nerve CSA is not useful for diagnosis. Most patients benefit from ultrasound-guided dextrose hydrodissection; however, those with scoliosis may experience symptom recurrence and whether structured rehabilitation can reduce recurrence post-injection should be considered as one perspective in future research.

Trial registration ClinicalTrials.gov (NCT04478344). Registered on 20 July 2020, https://clinicaltrials.gov/ct2/show/NCT04478344?cond=Superior+Cluneal+Nerve&cntry=TW&draw=2&rank=1.

Critical relevance statement Ultrasound imaging accurately locates SCN branches on the iliac crest, while enlargement of the CSA is not useful in diagnosing SCN entrapment; however, approximately 80% of SCN entrapment cases respond positively to ultrasound-guided dextrose hydrodissection.

Graphical abstract

Key Points

  • Ultrasound imaging accurately locates SCN branches on the iliac crest.

  • Enlargement of the CSA is not useful in diagnosing SCN entrapment.

  • Approximately 80% SCN entrapment cases respond positively to ultrasound-guided dextrose hydrodissection.

  • Scoliosis is associated with symptom recurrence in patients after successful injection.

Introduction

Low back pain has become a significant public health issue in recent years, with an age-standardized prevalence between 7.50–8.20% [1]. Despite being commonly overlooked or misdiagnosed during clinical practice, superior cluneal nerve (SCN) entrapment could account for up to 14% of cases with low back pain [2]. The SCN is the lateral cutaneous division of the L1–3 spinal nerve dorsal rami; it typically has three branches that innervate the skin of the upper buttock [3]. After piercing the erector spinae muscle to course underneath the thoracolumbar fascia, the medial branch of the SCN commonly passes through an osteofibrous tunnel on the iliac crest, where it is most commonly entrapped [4]. The usual presentation of SCN entrapment includes tenderness over the middle portion of the posterior iliac crest with pain radiating to the proximal gluteal region. The standard treatment for SCN entrapment involves nerve block with local anesthetics, whereas surgical release of the thoracolumbar fascia may be necessary in recalcitrant cases [5].

High-resolution ultrasound allows for the visualization of the SCN and relevant pathologies, such as neuritis, after posterior lumbar interbody fusion surgery [6, 7]. As a cutaneous nerve, a short-axis view of the terminal portion of the SCN is easily visible as a circular hypoechoic fascicle within a hyperechoic adipose background [8]. Notably, the SCN can be traced from the subcutaneous layer to the superficial fascia overlying the erector spinae using a distal-to-proximal approach. Although measurement of its cross-sectional area (CSA) is feasible, no studies have examined the usefulness of ultrasound-derived CSA for diagnosing SCN entrapment or for ultrasound-guided localization of the SCN on the iliac crest [5].

Ultrasound-guided SCN injections have been described to provide postsurgical analgesia for the upper buttock [9] or relieve painful SCN entrapment. To achieve the former, the fascial plane between the thoracolumbar fascia and erector spinae can be further fully hydro-dissected with local anesthetic infiltration [10]. For the latter, the target should be chosen close to the nerve's most compressive point, usually on the iliac crest [11]. A clinical trial is still needed to evaluate the effectiveness of ultrasound-guided injection for SCN entrapment. Accordingly, this study used cadaveric models, asymptomatic volunteers, and patients with SCN entrapment to explore (i) the course of SCN branches over the iliac crest, (ii) the SCN CSA at different levels and its diagnostic value, and (iii) the effects of ultrasound-guided hydrodissection and the prognosis thereafter.

Materials and methods

Ethical approval

Cadaver models were investigated with the approval of the Institute of Anatomy, First Faculty of Medicine, Charles University, Prague. Informed consent was obtained from healthy volunteers and patients. The study was approved by the Institutional Review Board of the National Taiwan University Hospital (201912037RINC) and registered at ClinicalTrials.gov (NCT04478344). The study flow is illustrated in Fig. 1.

Fig. 1
figure 1

Flow diagram of the cadaveric study (track 1), human volunteer study (track 2) and clinical trial (track 3) of ultrasound (US) guided injection for the superior cluneal nerves (SCN). PSIS, posterior superior iliac spine; CSA, cross-sectional area; PTT, pain pressure threshold; VAS, visual analogue scale of pain; ODI, Oswestry Disability Index

Techniques of ultrasound imaging and guided injection

A board-certified physiatrist who had been practicing musculoskeletal ultrasound for > 10 years conducted the scanning and guided injections using a linear probe at 5–18 MHz (HI VISION, Ascendus, Hitachi). Participants were placed in the prone position with their lumbar and gluteal regions exposed (Fig. 2A). First, the posterior superior iliac spine (PSIS) was located in the axial plane (Fig. 2B), and the ultrasound transducer was gradually moved in the cranial direction. As the gluteus maximus muscle faded away and the gluteus medius muscle emerged, a concavity on the iliac crest was visualized, representing the fibro-osseous tunnel that harbors the medial branch of the SCN (Fig. 2C) [11]. The transducer was then relocated more proximally to visualize the nerve situated between the thoracolumbar fascia and erector spinae (typically the multifidus and longissimus) muscles (Fig. 2D) [10].

Fig. 2
figure 2

A A, B, C and D inside the squares correspond to probe positioning for the subgraphs of A, B, C and D for scanning of the superior cluneal nerves (yellow lines and black arrowheads). B The probe is placed in the horizontal plane over the posterior superior iliac spine (PSIS) and (C) is then relocated more cranially to see the medial branch of the superior cluneal nerve embedded underneath the thoracolumbar fascia (white dashed line). D Moving the probe more cranially, the superior cluneal nerve is seen over the erector spinae muscle. E Shifting the probe more laterally, the three branches of the superior clunear nerve are identified along the posterior iliac crest (PIC). F Ultrasound guided hydrodissection is performed for the superior cluneal nerves using the in-plane, medial-to-lateral approach. MU, multifidus; GMAX, gluteus maximus; LO, longissimus; IC, iliocostalis; arrows, needle trajectory

Once the course of the medial SCN branch was determined, the transducer was shifted laterally and repositioned at the PSIS level. The medial end of the transducer was pivoted toward the S3 or S4 foramen to obtain a better axial view of the intermediate and lateral branches located in the subcutaneous tissue over the gluteus medius muscle. By moving the transducer cranially, the two aforementioned branches could be seen traveling across the iliac crest (Fig. 2E) [8]. The locations of the nerves were validated by provoking tingling sensations following the application of percutaneous electric stimulation using a Stimuplex HNS 12 nerve stimulator [12].

In patients who required ultrasound-guided nerve hydrodissection, a mixture of 1 mL 50% of dextrose, 4 mL of 1% lidocaine, and 5 mL of 0.9% normal saline was used primarily for the medial branch. Ultrasound guidance was used with an in-plane approach to target the branches of the SCN over the iliac crest. Additionally, the needle was gradually inserted using the medial-to-lateral approach to completely dissect the space between the thoracolumbar fascia and underlying bony cortex (Fig. 2F). The aforementioned injection technique was confirmed on a “Fix for Life” embalmed cadaver by successfully staining the SCN with methylene blue injection (Fig. 3A) [13].

Fig. 3
figure 3

A The medial branch of the superior cluneal nerve was stained by methylene blue following ultrasound guided injection on the cadavers. B The distance between the superior cluneal nerves over the iliac crest (white dots) and the posterior superior iliac spine (green dot) was measured along the horizontal and vertical axes (dashed lines)

Track 1: dissection study

An academic anatomist with > 25 years of experience performed the dissections. Twenty sides of 10 formalin-fixed cadavers (six males and four females with an average height and age at death of 164.7 cm and 78.7 years, respectively) were dissected. Following a transverse skin incision at approximately the 12th thoracic vertebral level, the skin was removed, and the SCNs were identified above the iliac crest by blunt dissection. They were then traced from the lateral margin of the erector spinae muscle, where they penetrated the thoracolumbar fascia to the point where they crossed the iliac crest (Fig. 3B). The points at which the SCN branches crossed the iliac crest were marked, and their distances relative to the PSIS near the level of the S2 foramen were measured.

Track 2: healthy volunteer study

Participants were enrolled if they were > 20 years and had no lower back or gluteal pain in the past year. Participants were excluded if they had previous trauma or injury to the lumbar or buttock areas. All the participants underwent bilateral clinical assessments and ultrasound scanning of the SCNs in a single session.

As the fascicles of the SCN were small, we utilized Image J software (National Institutes of Health, Bethesda, Maryland, USA) to measure their CSA, encompassing the epineurium, from the archived ultrasound images [14]. Horizontal and vertical distances of the SCNs on the iliac crest, in relation to the PSIS, were also evaluated. Additionally, a handheld algometer was used to quantify the pain threshold at the sites where the medial, intermediate, and lateral SCN branches crossed the iliac crest. The algometer was slowly and constantly applied to the target skin until the participant initially perceived tenderness with a visual analogue scale (VAS) score reaching 4 [15].

Track 3: study of patients with SCN entrapment

Patients with unilateral symptoms were recruited from the physical medicine and rehabilitation clinic if they were > 20 years and had low back pain that radiates to the ipsilateral gluteal region, as well as unilateral tenderness on the iliac crest. Patients were excluded if they had poor control of their existing medical conditions (e.g., diabetes mellitus), rheumatic disorders, lower back injections within the past year, or previous lumbar/pelvic surgery. Plain radiographs of the lumbosacral region were obtained from each patient to exclude the possibility of bony lesions. In our study, spondylosis was operationalized as a Kellgren and Lawrence grade of ≥ 2 [16], significant spondylolisthesis was defined as the presence of vertebral slippage [17], and scoliosis was characterized by Cobb's angle 10° [18]. Furthermore, if patients were found to have other lumbar or sacral pathologies, such as lumbar herniated disk with nerve root compression or sacroiliitis, identified from recent computed tomography or magnetic resonance imaging, they would also be excluded from this study. In patients with visible posterior facet joint arthrosis, they would be categorized in the group of spondylosis. It is important to note that a patient could have more than one of these pathologies, as indicated in the registry. Once the required data was collected, an ultrasound-guided perineural injection was performed on the painful side.

The ultrasound-derived CSA, pain threshold of the SCNs, and clinical progress were evaluated at baseline and one and three months after injection. Outcome assessment comprised the VAS for the worst pain experienced over the last 24 h and the Oswestry Disability Index (ODI) [19], which evaluates pain intensity and its impact on personal care, lifting, walking, sitting, standing, sleeping, sex, social interaction, and traveling.

Statistical analysis

Continuous variables are given as mean, standard deviation, and 95% confidence interval (CI); they were compared using the Mann–Whitney U test or visual inspection of their distribution on the blobbogram. If the 95% CIs of two effect size estimates did not overlap, they were considered significantly different [20]. Furthermore, the influence of age, sex, laterality, presence of entrapment, and being the painful site on the SCN CSA was investigated using generalized estimating equations [21], which are beneficial for analyzing data with repeated measurements or observations within the same individual or when the data are clustered by factors like location or time. Categorical variables are represented as percentages and were compared using the Chi-square test or Fisher’s exact (in the case of sparse data) test. Longitudinal data were analyzed using repeated-measures analysis of variance to examine changes over time. All analyses were conducted using SPSS 21.0 (IBM SPSS Statistics for Windows, Version 21.0, Armonk, NY, United States), and a p-value of < 0.05 was considered statistically significant.

Results

Location of the SCN on the iliac crest

On the cadavers, the average distance between the SCN and PSIS on the horizontal axis was 43.10–45.70 mm for the medial branch, 49.20–51.60 mm for the intermediate branch, and 54.20–56.10 mm for the lateral branch. The mean distance on the vertical axis was 63.40–63.70 mm for the medial branch, 69.60–71.10 mm for the intermediate branch, and 73.80–76.20 mm for the lateral branch. The measurements were similar between healthy volunteers and cadavers (Table 1, Fig. 4).

Table 1 The distance between the superior cluneal nerve on the iliac crest and posterior superior iliac spine on the horizontal and vertical axes of each branch
Fig. 4
figure 4

The mean value and 95% confidence interval of the distance between the superior cluneal nerves over the iliac crest and the posterior superior iliac spine on the (A) horizontal and (B) vertical axes. C., cadaver; V., asymptomatic volunteers; Rt., right; Lt., left; M., medial branch; I., intermediate branch; L., lateral branch; X., horizontal axis; Y., vertical axis

Cross-sectional area of the SCN

The average nerve CSA at baseline ranged between 4.69–5.67 mm2 across different branches and sides (Table 2). Generalized estimating equations analysis showed that age, sex, laterality, presence of entrapment, and site of pain did not have a significant impact on nerve size (Table 3). Furthermore, there was no significant difference (p = 0.982) in entrapped SCN CSA at the iliac crest level between individuals responding to injections (4.94 ± 1.20 mm2; 95% CI, 4.45 to 5.44) and those not responding to injections (5.13 ± 1.83 mm2; 95% CI, 3.44 to 6.83).

Table 2 Cross-sectional area of the superior cluneal nerve at different branches and sides
Table 3 Association of the cross-sectional area of the SCN with clinical characteristics

Pain pressure threshold on the iliac crest

There was no significant difference in the pressure threshold for pain between the right and left sides of the three branches of the SCN in asymptomatic volunteers. However, in patients with entrapment, a significantly lower threshold was observed on the painful side than on the asymptomatic side for all three branches (Additional file 1: Table S1).

Outcome of ultrasound-guided injection

A comparison of the demographics of asymptomatic volunteers and patients with SCN entrapment is presented in Additional file 1: Table S2. Among the 36 patients, a significant reduction in the VAS and ODI scores, along with an increase in the pressure threshold of pain on the injected side, was observed in the first and third months after the injection (Additional file 1: Table S3). However, there was no change in nerve CSA. The initial treatment success (i.e., VAS change > 1 mm at the first post-injection month) [22] was observed in 77.7% (n = 28) of the patients. Patients with treatment failure had lower baseline VAS scores than those with initial treatment success (Additional file 1: Table S4).

Symptom recurrence (i.e., third-month VAS ≥ baseline VAS) was observed in 25.0% (n = 7) of the patients with initial treatment success (Fig. 5). The group with recurrent pain had a higher prevalence of scoliosis than the group without recurrent pain (57.14% vs. 0.00%, p = 0.002; Table 4). None of the patients experienced any post-intervention adverse events.

Fig. 5
figure 5

A Visual analogue scale of pain and (B) Oswestry Disability Index at baseline, post-injection 1st and 3rd months for each group. Group 1, who did not respond to the initial treatment; Group 2, who initially responded to treatment but experienced symptom recurrence; and Group 3, who responded well to treatment and did not experience symptom recurrence

Table 4 Comparison between baseline characteristics of patients with and without symptom recurrence

Discussion

This study yielded several important results. First, the SCN locations crossing the iliac crest did not differ between the cadavers and asymptomatic volunteers, as confirmed by ultrasound imaging and electrical stimulation. Second, the CSA of the SCN did not vary across branches or in the presence of pain. Third, the average pain threshold decreased in all three SCN branches on the painful side. Fourth, approximately 80% of the patients responded successfully to ultrasound-guided 5% dextrose hydrodissection, whereas the rate of symptom recurrence was up to 25% in those with initial injection success.

The location of the SCN on the iliac crest has been previously delineated in cadaveric studies. In 2015, Loubser et al. [18] investigated 27 cadavers and reported that the average distance between the SCN piercing the thoracolumbar fascia and PSIS was 69.6 mm. In another study, Iwanaga et al. [19] dissected 10 freshly frozen cadavers and found that the mean distance from the bony groove on the iliac crest containing the medial SCN branch to the PSIS was 45.2 mm. In our cadaveric study, we specifically measured the distance between the above-crest SCN and PSIS along the horizontal and vertical axes to differentiate the reciprocal positions of different SCN branches on the same side. Using our measurement protocol, we found that the observations in cadavers were similar to the ultrasound findings in asymptomatic volunteers regarding the locations of all three SCN branches. This finding partially implies the validity of our sonographic approach. Furthermore, according to a recent systematic literature review [5], there is a lack of ultrasound studies investigating the precise location of the SCN on the iliac crest. In our investigation, we relied on a report describing the median branch of the SCN [23], which was observed to be embedded within the osteofibrous tunnel on the iliac crest.

Our study also revealed that ultrasonography-determined CSA has little value in the diagnosis of SCN entrapment. The use of CSA for diagnosing nerve entrapment is most evident in carpal and cubital tunnel syndromes, where the nerves usually become enlarged proximal to the compression site because of obstruction of the axoplasmic flow [24, 25]. However, unlike the median and ulnar nerves, which have considerable diameters owing to multiple intra-neural bundles, the SCN (being a cutaneous nerve) is small and has only a single nerve bundle [26]. The epineurium of the SCN contains a thick hyperechoic layer of adipose tissue, rendering the hypoechoic nerve bundles insignificant in terms of nerve CSA. Therefore, even if the nerve bundles become swollen because of entrapment, it is still challenging to differentiate them using ultrasound imaging. Our findings were consistent with those of an early case series comprising nine patients with SCN entrapment [6], which revealed significant nerve enlargement only in one patient after posterior lumbar interbody fusion.

Because tenderness over the iliac crest is considered mandatory for diagnosis, a decreased pain pressure threshold over the affected site is expected in SCN entrapment. It is important to note that increased pain sensitivity over the painful site was observed in all three branches of the nerve and not just in the medial branch. Tension of the thoracolumbar fascia is a common cause of SCN entrapment [27, 28]. The medial branch, which typically passes through a narrow fibro-osseous tunnel on the iliac crest, is most susceptible to compression; intermittent and lateral branches can also be affected, particularly in the segment that pierces the thoracolumbar fascia. Therefore, in patients with SCN entrapment, treatment with injections should include hydrodissection of the thoracolumbar fascia to maximize therapeutic effectiveness.

We observed an approximately 80% response rate to ultrasound-guided nerve hydrodissection, but several factors may have contributed to the remaining failed cases. For instance, the SCN could have been entrapped at multiple levels, such as inside the erector spinae muscle or in the subcutaneous layer, whereas our approach only targeted segments crossing the iliac crest. Additionally, ultrasound-guided intervention may not correct faulty biomechanics, such as excessive lumbar lordosis, which has been found to accentuate SCN entrapment. Finally, the SCN is in proximity to many common pain generators in the lumbosacral region, such as the lumbar facets, sacroiliac joints, and gluteus muscle insertions. Pathologies in these locations can generate symptoms similar to or concurrent with SCN entrapment.

Recurrent pain was observed in 25% of the patients who initially responded to the injection, and scoliosis was associated with recurrent pain after the initial treatment success. Scoliosis can cause asymmetry in the tension of the thoracolumbar fascia, which can alter the biomechanics of the spine and the surrounding muscles. An observational study also suggested that continued tightening of the fascial plane due to asymmetrical tension distribution could further increase scoliotic curvature [29]. Our findings indicate that although initial hydrodissection effectively relieves the compressed SCN, nerves may become repeatedly entrapped due to unbalanced posture factors. However, it is important to note that the exact causal relationship between recurrent pain and scoliosis requires further validation through large-scale studies.

For nerve hydrodissection, we used an injectate consisting of 5% dextrose, 1% lidocaine, and normal saline. Various regimens, including corticosteroids, platelet-rich plasma, and 5% dextrose, are commonly used for nerve hydrodissection. In case of carpal tunnel syndrome, a network meta-analysis has demonstrated that 5% dextrose is the most effective injectate for symptom relief [30]. Additionally, choosing 5% dextrose enables repeat injections at short intervals, which is otherwise not possible with corticosteroids because of their adverse effects on adjacent soft tissues. Furthermore, the long-term effect of 5% dextrose injection has been implied by a previous randomized controlled trial [31], showing 5% dextrose to be more effective than corticosteroid injection in patients with mild-to-moderate carpal tunnel syndrome at 4 to 6 months post-injection. Our study also implies that repeat injections, such as hydrodissection along the nerve’s long axis (to cover the subcutaneous or intramuscular segments), may be needed in cases of initial treatment failure or when using the same injection approach for symptom recurrence in patients with primary treatment success.

This study has several limitations. First, the injection techniques were validated at only two sites on a cadaver. This was due to the fact that if the methylene blue staining was used on the other 10 cadavers, the exact locations of the SCN on the iliac crest might have not been accurately located. Second, we did not administer placebo injections over the subcutaneous layer or other sham treatments for comparison with the patient group. Our clinical objective was to investigate the responsiveness and predictors of ultrasound-guided 5% dextrose hydrodissection for SCN entrapment; therefore, future studies are needed to explore the comparative effectiveness of our approach with other treatment methods. Third, structured rehabilitation was not incorporated after the injection. Considering that scoliosis is associated with symptom recurrence, it may be necessary to include physical therapy and exercise interventions in standard post-injection care to reduce thoracolumbar fascial tension and improve pelvic symmetry. Fourth, our study only followed patients for a period of three months, leaving the long-term effects of ultrasound-guided intervention unknown. Additionally, our strict inclusion criteria excluded patients with nonspecific low back pain who did not exhibit tenderness over the iliac crest. Future studies are necessary to explore the duration of the effect of ultrasound-guided SCN hydrodissection and determine whether the benefits of this intervention can extend to a broader patient population beyond those with SCN entrapment alone. Fifth, we did not routinely arrange all patients with initial injection failure or recurrent pain for EOS imaging [32], magnetic resonance imaging, or computed tomography. It is possible that unsuccessful treatment or symptom recurrence could be attributed to mild/moderate facet arthrosis or sacroiliac joint pathology, which would require the aforementioned advanced imaging systems for investigation.

Conclusion

Ultrasound imaging enables the localization of SCN branches on the iliac crest, and the findings are similar to those of cadaveric dissections. Enlargement of the nerve CSA is not useful for diagnosing SCN entrapment, and approximately 80% of cases respond positively to ultrasound-guided dextrose hydrodissection. Scoliosis is associated with symptom recurrence in patients with successful initial injections, and whether structured rehabilitation can reduce recurrence post-injection should be considered as one perspective in future research.

Availability of data and materials

The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.

Abbreviations

CI:

Confidence interval

CSA:

Cross-sectional area

ODI:

Oswestry Disability Index

PSIS:

Posterior superior iliac spine

SCN:

Superior cluneal nerve

VAS:

Visual analog scale

References

  1. Wu A, March L, Zheng X et al (2020) Global low back pain prevalence and years lived with disability from 1990 to 2017: estimates from the Global Burden of Disease Study 2017. Ann Transl Med 8:299

    Article  PubMed  PubMed Central  Google Scholar 

  2. Kuniya H, Aota Y, Kawai T, Kaneko K, Konno T, Saito T (2014) Prospective study of superior cluneal nerve disorder as a potential cause of low back pain and leg symptoms. J Orthop Surg Res 9:139

    Article  PubMed  PubMed Central  Google Scholar 

  3. Karl HW, Helm S, Trescot AM (2022) Superior and middle cluneal nerve entrapment: a cause of low back and radicular pain. Pain Physician 25:E503-e521

    PubMed  Google Scholar 

  4. Ricci V, Özçakar L (2020) Ultrasound imaging for the medial branches of the superior cluneal nerve: optimal visibility at the “fatty tunnel.” Pain Pract 20:338–339

    Article  PubMed  Google Scholar 

  5. Wu WT, Mezian K, Nanka O, Chang KV, Ozcakar L (2022) Ultrasonographic imaging and guided intervention for the superior cluneal nerve: a narrative pictorial review. Pain Physician 25:E657–E667

    PubMed  Google Scholar 

  6. Bodner G, Platzgummer H, Meng S, Brugger PC, Gruber GM, Lieba-Samal D (2016) Successful identification and assessment of the superior cluneal nerves with high-resolution sonography. Pain Physician 19:197–202

    PubMed  Google Scholar 

  7. Wu WT, Hsu YC, Mezian K, Ricci V, Chang KV, Ozcakar L (2023) Ultrasound imaging and guided intervention for the middle cluneal nerve. Med Ultrason 25:119–120

    Article  PubMed  Google Scholar 

  8. Chang KV, Wu WT (2019) Is it possible to exactly visualize the superior cluneal nerve using ultrasound imaging? Reg Anesth Pain Med. https://doi.org/10.1136/rapm-2019-100731

    Article  PubMed  Google Scholar 

  9. Fan K, Cheng C, Gong WY (2021) A simple and novel ultrasound-guided approach for superior cluneal nerves block. Anaesth Crit Care Pain Med 40:100838

    Article  PubMed  Google Scholar 

  10. Nielsen TD, Moriggl B, Barckman J et al (2019) Randomized trial of ultrasound-guided superior cluneal nerve block. Reg Anesth Pain Med. https://doi.org/10.1136/rapm-2018-100174

    Article  PubMed  Google Scholar 

  11. Chang KV, Hsu SH, Wu WT, Özçakar L (2017) Ultrasonographic technique for imaging and injecting the superior cluneal nerve. Am J Phys Med Rehabil 96:e117–e118

    Article  PubMed  Google Scholar 

  12. Jochum D, Iohom G, Diarra DP, Loughnane F, Dupré LJ, Bouaziz H (2006) An objective assessment of nerve stimulators used for peripheral nerve blockade*. Anaesthesia 61:557–564

    Article  CAS  PubMed  Google Scholar 

  13. van Emden MW, Geurts JJG, Schober P, Schwarte LA (2020) Suitability and realism of the novel Fix for Life cadaver model for videolaryngoscopy and fibreoptic tracheoscopy in airway management training. BMC Anesthesiol 20:203

    Article  PubMed  PubMed Central  Google Scholar 

  14. Wu WT, Chang KV, Mezian K, Naňka O, Lin CP, Özçakar L (2018) Basis of shoulder nerve entrapment syndrome: an ultrasonographic study exploring factors influencing cross-sectional area of the suprascapular nerve. Front Neurol 9:902

    Article  PubMed  PubMed Central  Google Scholar 

  15. Escalona-Marfil C, Coda A, Ruiz-Moreno J, Riu-Gispert LM, Gironès X (2020) Validation of an electronic visual analog scale mhealth tool for acute pain assessment: prospective cross-sectional study. J Med Internet Res 22:e13468

    Article  PubMed  PubMed Central  Google Scholar 

  16. Chen L, Perera RS, Radojcic MR et al (2021) Association of lumbar spine radiographic changes with severity of back pain-related disability among middle-aged, community-dwelling women. JAMA Netw Open 4:e2110715

    Article  PubMed  PubMed Central  Google Scholar 

  17. Koslosky E, Gendelberg D (2020) Classification in brief: the meyerding classification system of spondylolisthesis. Clin Orthop Relat Res 478:1125–1130

    Article  PubMed  PubMed Central  Google Scholar 

  18. Horng MH, Kuok CP, Fu MJ, Lin CJ, Sun YN (2019) Cobb angle measurement of spine from x-ray images using convolutional neural network. Comput Math Methods Med 2019:6357171

    Article  PubMed  PubMed Central  Google Scholar 

  19. Fairbank JC, Pynsent PB (2000) The oswestry disability index. Spine (Phila Pa 1976) 25:2940–2952

    Article  CAS  PubMed  Google Scholar 

  20. Cumming G, Finch S (2001) A primer on the understanding, use, and calculation of confidence intervals that are based on central and noncentral distributions. Educ Psychol Meas 61:532–574

    Article  Google Scholar 

  21. LiangZeger K-YSL (1986) Longitudinal data analysis using generalized linear models. Biometrika 73:13–22

    Article  Google Scholar 

  22. Kelly AM (2001) The minimum clinically significant difference in visual analogue scale pain score does not differ with severity of pain. Emerg Med J 18:205–207

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Ricci V, Özçakar L (2019) Ultrasound imaging of the superior cluneal nerve: Sonoanatomy of the osteo-fibrous tunnel revisited. Clin Anat 32:466–467

    Article  PubMed  Google Scholar 

  24. Lin TY, Chang KV, Wu WT, Ozcakar L (2022) Ultrasonography for the diagnosis of carpal tunnel syndrome: an umbrella review. J Neurol 269:4663–4675

    Article  PubMed  Google Scholar 

  25. Chang KV, Wu WT, Han DS, Ozcakar L (2018) Ulnar nerve cross-sectional area for the diagnosis of cubital tunnel syndrome: a meta-analysis of ultrasonographic measurements. Arch Phys Med Rehab 99:743–757

    Article  Google Scholar 

  26. Chang KV, Mezian K, Nanka O et al (2018) Ultrasound imaging for the cutaneous nerves of the extremities and relevant entrapment syndromes: from anatomy to clinical implications. J Clin Med 7:457

    Article  PubMed  PubMed Central  Google Scholar 

  27. Willard FH, Vleeming A, Schuenke MD, Danneels L, Schleip R (2012) The thoracolumbar fascia: anatomy, function and clinical considerations. J Anat 221:507–536

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Isu T, Kim K, Morimoto D, Iwamoto N (2018) Superior and middle cluneal nerve entrapment as a cause of low back pain. Neurospine 15:25–32

    Article  PubMed  PubMed Central  Google Scholar 

  29. Whyte Ferguson L (2017) Adolescent idiopathic scoliosis: the Tethered Spine III: Is fascial spiral the key? J Bodyw Mov Ther 21:948–971

    Article  PubMed  Google Scholar 

  30. Lin CP, Chang KV, Huang YK, Wu WT, Ozcakar L (2020) Regenerative injections including 5% dextrose and platelet-rich plasma for the treatment of carpal tunnel syndrome: a systematic review and network meta-analysis. Pharmaceuticals (Basel) 13:49

    Article  CAS  PubMed  Google Scholar 

  31. Wu YT, Ke MJ, Ho TY, Li TY, Shen YP, Chen LC (2018) Randomized double-blinded clinical trial of 5% dextrose versus triamcinolone injection for carpal tunnel syndrome patients. Ann Neurol 84:601–610

    Article  CAS  PubMed  Google Scholar 

  32. Garg B, Mehta N, Bansal T, Malhotra R (2020) EOS® imaging: concept and current applications in spinal disorders. J Clin Orthop Trauma 11:786–793

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

The pictures of the anatomical specimens were created using donated bodies with the approval of the Institute of Anatomy, First Faculty of Medicine, Charles University, Prague. The authors sincerely thank those who donated their bodies to science so that anatomical research could be performed. The results of such research have the potential to increase mankind's overall knowledge, which could improve patient care. Therefore, these donors and their families deserve our highest gratitude.

Funding

The study was made possible by (1) the research funding (11202 and 112-BH002) of National Taiwan University Hospital and its Bei-Hu Branch, Taipei, Taiwan; (2) Ministry of Science and Technology (MOST 106-2314-B-002-180-MY3, 109-2314-B-002-114-MY3, 109-2314-B-002-127, 110-2314-B-002-069 and 111-2314-B-002-161), (3) Taiwan Society of Ultrasound in Medicine and (4) Charles University Cooperatio project -Morphological Disciplines of Medicine.

Author information

Authors and Affiliations

Authors

Contributions

WTW, LRC, KVC, LÖ conceived and designed the study. WTW, KM, ON, LRC, KVC collected data. WTW, CPL, KVC, LÖ prepared the manuscript. LRC, VR, CPL performed the data analysis and interpretation. WTW, LRC, VR, KVC, LÖ drafted and revised the manuscript. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Ke-Vin Chang.

Ethics declarations

Competing interests

No conflicts of interest have been reported by the authors or by any individual in control of the content of this article.

Ethics approval and consent to participate

The research protocol was approved by the Institutional Review Board of the hospital (201912037RINC), and all eligible participants provided written informed consent before enrollment.

Consent for publication

Not applicable.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Additional file 1.

Supplemental tables.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Wu, WT., Mezian, K., Naňka, O. et al. Enhancing diagnosis and treatment of superior cluneal nerve entrapment: cadaveric, clinical, and ultrasonographic insights. Insights Imaging 14, 116 (2023). https://doi.org/10.1186/s13244-023-01463-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s13244-023-01463-0

Keywords